Tags

Type your tag names separated by a space and hit enter

Novel coronavirus disease (COVID-19) in children
Turk J Med Sci. 2020 04 21; 50(SI-1):592-603.TJ

Abstract

Coronavirus disease (COVID-19) was firstly reported at the end of 2019. The disease rapidly spread all around the world in a few months and was declared a worldwide pandemic by WHO in March 2020. By April 9, there were 1,436,198 confirmed COVID-19 cases in the world, nearly with 6% mortality rate. This novel infectious disease causes respiratory tract illness that may generally occur as mild upper respiratory tract disease or pneumonia. In older patients and/or patients with underlying conditions, it may result in acute respiratory distress syndrome, multi organ failure and even death. According to the current literature, children account approximately for 1%–5% of diagnosed COVID-19 cases. Generally, COVID-19 seems to be a less severe disease for children than adults. Approximately 90% of pediatric patients are diagnosed as asymptomatic, mild, or moderate disease. However, up to 6.7% of cases may be severe. Severe illness is generally seen in patients smaller than 1 year of age and patients who have underlying disesases. The epidemiological and clinical patterns of COVID-19 and treatment approaches in pediatric patients still remain unclear although many pediatric reports are published. This review aims to summarize the current epidemics, clinical presentations, diagnosis, and treatment of COVID-19 in pediatric patients.

Authors+Show Affiliations

Department of Pediatric Infectious Disease, Faculty of Medicine, Gazi University, Ankara, TurkeyDepartment of Pediatric Infectious Disease, Ankara City Hospital, Ankara, Turkey

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32304191

Citation

Tezer, Hasan, and Tuğba Bedir Demirdağ. "Novel Coronavirus Disease (COVID-19) in Children." Turkish Journal of Medical Sciences, vol. 50, no. SI-1, 2020, pp. 592-603.
Tezer H, Bedir Demirdağ T. Novel coronavirus disease (COVID-19) in children. Turk J Med Sci. 2020;50(SI-1):592-603.
Tezer, H., & Bedir Demirdağ, T. (2020). Novel coronavirus disease (COVID-19) in children. Turkish Journal of Medical Sciences, 50(SI-1), 592-603. https://doi.org/10.3906/sag-2004-174
Tezer H, Bedir Demirdağ T. Novel Coronavirus Disease (COVID-19) in Children. Turk J Med Sci. 2020 04 21;50(SI-1):592-603. PubMed PMID: 32304191.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Novel coronavirus disease (COVID-19) in children AU - Tezer,Hasan, AU - Bedir Demirdağ,Tuğba, Y1 - 2020/04/21/ PY - 2020/04/16/received PY - 2020/04/17/accepted PY - 2020/4/19/entrez PY - 2020/4/19/pubmed PY - 2020/4/23/medline KW - COVID-19 KW - Novel corona virus KW - pediatrics SP - 592 EP - 603 JF - Turkish journal of medical sciences JO - Turk J Med Sci VL - 50 IS - SI-1 N2 - Coronavirus disease (COVID-19) was firstly reported at the end of 2019. The disease rapidly spread all around the world in a few months and was declared a worldwide pandemic by WHO in March 2020. By April 9, there were 1,436,198 confirmed COVID-19 cases in the world, nearly with 6% mortality rate. This novel infectious disease causes respiratory tract illness that may generally occur as mild upper respiratory tract disease or pneumonia. In older patients and/or patients with underlying conditions, it may result in acute respiratory distress syndrome, multi organ failure and even death. According to the current literature, children account approximately for 1%–5% of diagnosed COVID-19 cases. Generally, COVID-19 seems to be a less severe disease for children than adults. Approximately 90% of pediatric patients are diagnosed as asymptomatic, mild, or moderate disease. However, up to 6.7% of cases may be severe. Severe illness is generally seen in patients smaller than 1 year of age and patients who have underlying disesases. The epidemiological and clinical patterns of COVID-19 and treatment approaches in pediatric patients still remain unclear although many pediatric reports are published. This review aims to summarize the current epidemics, clinical presentations, diagnosis, and treatment of COVID-19 in pediatric patients. SN - 1303-6165 UR - https://www.unboundmedicine.com/medline/citation/32304191/Novel_coronavirus_disease__COVID_19__in_children L2 - https://doi.org/10.3906/sag-2004-174 DB - PRIME DP - Unbound Medicine ER -